Back to Search
Start Over
AstraZeneca reports Fasenra approved in China for severe eosinophilic asthma
- Source :
- The Fly. August 20, 2024
- Publication Year :
- 2024
-
Abstract
- AstraZeneca's Fasenra has been approved in China by the country's National Medical Products Association, or NMPA, for the maintenance treatment of patients 12 years of age and older with severe [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.805493089